Corcept Therapeutics Inc (NASDAQ:CORT)

16.48
Delayed Data
As of Feb 23
 +0.39 / +2.42%
Today’s Change
8.37
Today|||52-Week Range
25.96
-8.75%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues26.6M50.3M81.3M159.2M
 
 
 
 
 
Cost of Goods Sold741.0K1.2M2.0M3.6M
 
 
 
 
 
Depreciation And Amortization141.0K155.0K87.0K--
 
 
 
 
 
Operating ExpensesGross Income25.7M48.9M79.3M155.6M
 
 
 
 
 
General Expenses53.3M52.4M69.1M102.8M
 
 
 
 
 
Research And Development18.4M15.4M23.8M40.4M
 
 
 
 
 
Total Operating Expenses54.2M53.7M71.1M106.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-27.6M-3.4M10.2M52.9M
 
 
 
 
 
Interest Expense On Debt3.7M2.8M1.9M49.0K
 
 
 
 
 
Other Expenses-64.0K-165.0K-110.0K--
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-31.4M-6.4M8.1M52.8M
 
 
 
 
 
Income Taxes0.000.000.00-76.3M
 
 
Net Income-31.4M-6.4M8.1M129.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS101.0M106.9M110.6M113.5M
 
 
 
 
 
Shares To Calculate EPS Diluted101.0M106.9M110.6M124.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.31-$0.06$0.07$1.04
 
 
 
 
 
EPS Diluted-$0.31-$0.06$0.07$1.04